Cargando…

Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes

BACKGROUND: Solar ultraviolet radiation (UV) induces DNA damages in skin via direct absorption of UVB or indirectly by photosensitization mediated through UVA. Recent findings have revealed that UVA induces cyclobutane pyrimidine dimer (CPD) generation via chemiexcitation in melanocytes hours after...

Descripción completa

Detalles Bibliográficos
Autores principales: Yim, Sunghan, Lee, Jeesun, Jo, Hae, Scholten, Jeff, Willingham, Ryan, Nicoll, Jim, Baswan, Sudhir M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859469/
https://www.ncbi.nlm.nih.gov/pubmed/32009811
http://dx.doi.org/10.2147/CCID.S223802
_version_ 1783471122825609216
author Yim, Sunghan
Lee, Jeesun
Jo, Hae
Scholten, Jeff
Willingham, Ryan
Nicoll, Jim
Baswan, Sudhir M
author_facet Yim, Sunghan
Lee, Jeesun
Jo, Hae
Scholten, Jeff
Willingham, Ryan
Nicoll, Jim
Baswan, Sudhir M
author_sort Yim, Sunghan
collection PubMed
description BACKGROUND: Solar ultraviolet radiation (UV) induces DNA damages in skin via direct absorption of UVB or indirectly by photosensitization mediated through UVA. Recent findings have revealed that UVA induces cyclobutane pyrimidine dimer (CPD) generation via chemiexcitation in melanocytes hours after the exposure. This UVA-induced delayed CPD (dark CPD) constitutes the majority of CPD in melanocytes. These findings indicate that sun light can damage the skin hours after the exposure, suggesting the need for skin care products post sun exposure. The main objective of this study was to investigate whether a blend of Chrysanthemum Morifolium flower extract (Chrys) and vitamin C derivative, Ascorbic Acid-2-Glucoside (AA2G), can provide protective effects against reactive oxygen species, melanin formation and UVA-induced dark CPD. METHODS: Intracellular ROS levels were measured in epidermal keratinocytes using DHR123 dye. Melanogenesis inhibition efficacy was determined using B16 cells. As for the dark CPD measurement, Melan-a cells were treated with or without actives for 6 days, then irradiated with UVA at various doses. Cells were exposed with anti-CPD mAb followed by secondary Ab. CPD levels were determined by measuring fluorescent intensity using a high content imaging analysis. RESULTS: Chrys, AA2G and their blend at various concentrations demonstrated ROS scavenging activity. Though Chrys alone did not show significant melanogenesis inhibition in B16 assay, the blend of Chrys with AA2G demonstrated additive effects in comparison with AA2G alone. The blend of AA2G and Chrys at various concentrations exhibited enhanced efficacy for inhibiting dark CPD compared to AA2G alone. CONCLUSION: The results from this study indicate that the use of natural antioxidant, Chrys in combination with AA2G, provides protection against UVA-induced delayed CPD formation by enhancing ROS scavenging activity and melanogenesis inhibition. These findings could potentially be applied for formulating post-sun exposure skin care products, possibly extending to evening-after care products.
format Online
Article
Text
id pubmed-6859469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-68594692020-01-31 Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes Yim, Sunghan Lee, Jeesun Jo, Hae Scholten, Jeff Willingham, Ryan Nicoll, Jim Baswan, Sudhir M Clin Cosmet Investig Dermatol Original Research BACKGROUND: Solar ultraviolet radiation (UV) induces DNA damages in skin via direct absorption of UVB or indirectly by photosensitization mediated through UVA. Recent findings have revealed that UVA induces cyclobutane pyrimidine dimer (CPD) generation via chemiexcitation in melanocytes hours after the exposure. This UVA-induced delayed CPD (dark CPD) constitutes the majority of CPD in melanocytes. These findings indicate that sun light can damage the skin hours after the exposure, suggesting the need for skin care products post sun exposure. The main objective of this study was to investigate whether a blend of Chrysanthemum Morifolium flower extract (Chrys) and vitamin C derivative, Ascorbic Acid-2-Glucoside (AA2G), can provide protective effects against reactive oxygen species, melanin formation and UVA-induced dark CPD. METHODS: Intracellular ROS levels were measured in epidermal keratinocytes using DHR123 dye. Melanogenesis inhibition efficacy was determined using B16 cells. As for the dark CPD measurement, Melan-a cells were treated with or without actives for 6 days, then irradiated with UVA at various doses. Cells were exposed with anti-CPD mAb followed by secondary Ab. CPD levels were determined by measuring fluorescent intensity using a high content imaging analysis. RESULTS: Chrys, AA2G and their blend at various concentrations demonstrated ROS scavenging activity. Though Chrys alone did not show significant melanogenesis inhibition in B16 assay, the blend of Chrys with AA2G demonstrated additive effects in comparison with AA2G alone. The blend of AA2G and Chrys at various concentrations exhibited enhanced efficacy for inhibiting dark CPD compared to AA2G alone. CONCLUSION: The results from this study indicate that the use of natural antioxidant, Chrys in combination with AA2G, provides protection against UVA-induced delayed CPD formation by enhancing ROS scavenging activity and melanogenesis inhibition. These findings could potentially be applied for formulating post-sun exposure skin care products, possibly extending to evening-after care products. Dove 2019-11-13 /pmc/articles/PMC6859469/ /pubmed/32009811 http://dx.doi.org/10.2147/CCID.S223802 Text en © 2019 Yim et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yim, Sunghan
Lee, Jeesun
Jo, Hae
Scholten, Jeff
Willingham, Ryan
Nicoll, Jim
Baswan, Sudhir M
Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title_full Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title_fullStr Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title_full_unstemmed Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title_short Chrysanthemum Morifolium Extract And Ascorbic Acid-2-Glucoside (AA2G) Blend Inhibits UVA-Induced Delayed Cyclobutane Pyrimidine Dimer (CPD) Production In Melanocytes
title_sort chrysanthemum morifolium extract and ascorbic acid-2-glucoside (aa2g) blend inhibits uva-induced delayed cyclobutane pyrimidine dimer (cpd) production in melanocytes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859469/
https://www.ncbi.nlm.nih.gov/pubmed/32009811
http://dx.doi.org/10.2147/CCID.S223802
work_keys_str_mv AT yimsunghan chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT leejeesun chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT johae chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT scholtenjeff chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT willinghamryan chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT nicolljim chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes
AT baswansudhirm chrysanthemummorifoliumextractandascorbicacid2glucosideaa2gblendinhibitsuvainduceddelayedcyclobutanepyrimidinedimercpdproductioninmelanocytes